The Long-Term Outcomes of Patients with Chemotherapy-Induced Cardiomyopathy Undergoing Heart Transplantation

Purpose: Chemotherapy-induced cardiomyopathy (CCMP) is observed in up to 10% of cancer survivors. Progression into end-stage heart failure occurs in 2-4% of those patients. In individuals in complete remission who develop end-stage heart failure an orthotopic heart transplantation (OHT) is a viable option. The data on the contemporary long-term post-OHT outcomes in CCMP patients is scarce.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Source Type: research